Cellino Biotech
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $95M
Investors
- 6
About Cellino Biotech
Founded in 2017, Cellino Biotech, Inc. operates out of Cambridge, US, and focuses on creating personalized regenerative therapies. The company is co-founded by Nabiha Saklayen, who has a history in biotech entrepreneurship.Cellino Bio specializes in advanced regenerative medicine, focusing on patient-specific therapies derived from adult autologous stem cells. Their core offerings center around the Nebula™ platform, which utilizes AI-driven optical bioprocesses to facilitate the biomanufacturing of living medicines, such as cell, tissue, and organ replacements tailored for individuals suffering from chronic degenerative diseases. This innovative technology enhances treatment experiences by providing scalable, reproducible, and precise manufacturing capabilities. The company's solutions are designed for healthcare providers and institutions, enabling expanded patient access to advanced therapies.Cellino’s revenue structure is primarily driven by partnerships and collaborations within the healthcare sector, particularly with hospitals and specialized clinics. The company engages in B2B transactions, supplying its Nebula™ platform and associated technologies to healthcare providers who implement these advanced therapies in their treatment offerings. Revenue is generated through the sale of technology licenses, service agreements, and potentially through direct sales of proprietary therapies. The transaction framework is designed to support scalable deployment of their systems, enabling providers to offer Cellino’s innovative treatments to their patients efficiently.00 mn in November 2021, Cellino Biotech, Inc. plans to expand its machine learning, software, and hardware capabilities. The company aims to further its reach in North America and Europe, where it intends to launch new products that enhance their current offerings in personalized regenerative medicine.
Who invested in Cellino Biotech
6 investors across 2 rounds
See all investors in Cellino Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cellino Biotech
Who invested in Cellino Biotech?
Cellino Biotech has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellino Biotech raised?
Cellino Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cellino Biotech last raise money?
Cellino Biotech's most recent round on record is a Series A, in Nov 2021.
What does Cellino Biotech do?
Founded in 2017, Cellino Biotech, Inc.
Where is Cellino Biotech headquartered?
Cellino Biotech is headquartered in Cambridge, US.
Which VCs invest in companies like Cellino Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cellino Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cellino Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.